Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Nov-Dec;28(9):558-83.
doi: 10.1016/j.nrl.2013.05.002. Epub 2013 Jul 21.

Advanced Parkinson's disease: clinical characteristics and treatment. Part II

[Article in English, Spanish]
Affiliations
Free article
Review

Advanced Parkinson's disease: clinical characteristics and treatment. Part II

[Article in English, Spanish]
J Kulisevsky et al. Neurologia. 2013 Nov-Dec.
Free article

Abstract

Introduction: Many patients who have had Parkinson's disease (PD) for several years will present severe motor fluctuations and dyskinesias which require more aggressive therapies. The different approaches which are now available include deep brain stimulation of the subthalamic nucleus or medial globus pallidus, subcutaneous infusion of apomorphine, and intestinal infusion of levodopa-carbidopa.

Objective: To define the indications and results for the 3 available therapies for advanced PD.

Development: Exhaustive review of the literature concerning the indications and results of deep brain stimulation, subcutaneous apomorphine infusion and duodenal infusion of levodopa/carbidopa gel to treat patients with advanced Parkinson disease.

Conclusions: Although numerous studies have confirmed the efficacy of the 3 different therapies in advanced PD, there are no comparative studies that would allow us to define the best candidate for each technique.

Keywords: Advanced Parkinson's disease; Deep brain stimulation; Enfermedad de Parkinson avanzada; Estimulación cerebral profunda; Infusión de apomorfina; Infusión intestinal de levodopa-carbidopa; Intestinal levodopa-carbidopa infusion; Subcutaneous apomorphine infusion.

PubMed Disclaimer

MeSH terms

LinkOut - more resources